Response to 'Nalmefene in alcohol-dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption'

首页> 外文期刊>Psychiatry and clinical neurosciences >Response to 'Nalmefene in alcohol-dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption'

【24h】

Response to 'Nalmefene in alcohol-dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption'

机译：对饮酒风险高饮酒患者的“Nalmefene”的反应：降低酒精消费的有限效果'

获取原文

获取原文并翻译 | 示例

开具论文收录证明 >>

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Psychiatry and clinical neurosciences》 |2020年第4期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Response to 'Nalmefene in alcohol-dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption' [J] . Psychiatry and clinical neurosciences . 2020,第3a4期

机译：对饮酒风险高饮酒患者的“Nalmefene”的反应：降低酒精消费的有限效果'
2. The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective [J] . Brodtkorb Thor-Henrik, Bell Melissa, Irving Adam H., CNS drugs . 2016,第2期

机译：从英国社会的角度来看，Nalmefene降低高或极高饮酒风险水平的酒精依赖患者的酒精消耗的成本效益
3. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model [J] . Carolina Barbosa, Chris Knight, Clément Fran?ois, BMJ Open . 2014,第9期

机译：纳美芬的成本效益和公共卫生效益增加了社会心理支持，以减少高/非常高饮酒风险水平的酒精依赖患者的饮酒量：马尔可夫模型
4. Why Do You Drink? Virtual Reality As An Experiential Medium For The Assessment Of Alcohol-Dependent Individuals [C] . Elena GATTI, Rosanna MASSARI, Cinzia SACCHELLI, Medicine Meets Virtual Reality . 2008

机译：你为什么喝酒？虚拟现实作为评估酒精依赖性个人的体验媒体
5. Memory impairment in abstinent alcohol-dependent patients: A research synthesis and meta-analysis. [D] . Allen, Kenneth Edward. 2015

机译：戒酒依赖者的记忆障碍：一项研究综合和荟萃分析。
6. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model [O] . Philippe Laramée, Thor-Henrik Brodtkorb, Nora Rahhali, 2014

机译：纳美芬的成本效益和公共卫生效益增加了社会心理支持以减少高/非常高饮酒风险水平的酒精依赖患者的饮酒量：马尔可夫模型
7. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model. [O] . Laramée, P., Brodtkorb, T.H., Rahhali, N., 2014

机译：纳美芬的成本效益和公共卫生效益为减少高/非常高饮酒风险水平的酒精依赖患者的饮酒量提供了社会心理支持：马尔可夫模型。

Response to 'Nalmefene in alcohol-dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption'

著录项

引文网络

相似文献

相关主题

期刊订阅